Bausch & Lomb

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug alert for Bausch & Lomb’s Emerade adrenaline auto-injector device. Read more


Renowned contact lens manufacturer Bausch & Lomb has been sold for US$8.7 bn to Canada's Valeant Pharmaceuticals. The sale was first mooted publicly in December 2012, with rumours of an IPO in April. Sam Anson reports and comments. Read more


Oxygen transmissability to the open eye

Source: Bausch & Lomb.

Development of contact lens materials has accelerated in the last century since the advent of the original glass shell lenses. Sean Lyons of Bausch & Lomb looks at some of the latest advances. Read more